NCT02858271

Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778

An Open-Label, Single-Dose, Phase 1 Study to Assess the Absorption, Metabolism, Excretion, and Pharmacokinetics of [14C]-AKB-9778 in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: Aerpio Therapeutics · Industry
• Sex: Male
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

Open-label, single-dose, Phase 1 study to assess the absorption, metabolism, excretion and pharmacokinetics of \[14C\]-AKB-9778 in healthy male volunteers

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	AKB-9778 subcutaneous injection

Timeline

• Start date: 2016-07-01
• Primary completion: 2016-07-01
• Completion: 2016-07-01
• First posted: 2016-08-08
• Last updated: 2016-08-08